Research on Plants Sources of Natural Anticancer Drugs

Yu Bin Ji; Si Ting Wang; Qi Chang Dai; Peng Tian; Xiao Han

doi:10.4028/www.scientific.net/AMM.411-414.3246

Paper Titles

Optimizing Discriminant Model for Improved Classification of Protein
p.3227

Research on Structural Modification and Structure-Activity Relationship about Anti-Tumor of Polysaccharides from Plants
p.3232

New Research on the Pharmaceutical Chemistry of Plant Polysaccharides
p.3237

New Progress about Apoptosis Factors of Tumor Cell
p.3242

Research on Plants Sources of Natural Anticancer Drugs
p.3246

Research Advances in the Anti-Tumor Angiogenesis of Flavonoids
p.3250

A Study on the Fully Controlled Crop Cultivation System for the Development of Medicinal Crop Cultivation Model
p.3254

The Advance of Protozoa as the Model Animal in the Environment
p.3258

Study on Hodgkin-Huxley Neuron Model under Disturbance
p.3261

HomeApplied Mechanics and MaterialsApplied Mechanics and Materials Vols. 411-414Research on Plants Sources of Natural Anticancer...

Research on Plants Sources of Natural Anticancer Drugs

Abstract:

With the rising incidence of cancer, the research of natural medicine anti-cancer becomes a hot spot. This article used several typical activities compounds from plants such as Taxaceae, Davidia involucrata branch, Lily section, Fabaceae, Labiatae, oleander branch, Zingiberaceae, and Celastraceae, and then analyzed the activity of different types of cancer anticancer.

You might also be interested in these eBooks

View Preview

Info:

Periodical:

Applied Mechanics and Materials (Volumes 411-414)

Pages:

3246-3249

DOI:

https://doi.org/10.4028/www.scientific.net/AMM.411-414.3246

Citation:

Cite this paper

Online since:

September 2013

Authors:

Yu Bin Ji, Si Ting Wang, Qi Chang Dai, Peng Tian, Xiao Han

Keywords:

Anticancer, Natural Drugs, Plants Sources

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

Citation:

References

[1] Lee MS, Yuet-Wa JC, Kong SK, et, al. Cancer Biol Ther, Vol. 4(2005), pp.1248-1254.

Google Scholar

[2] Siu FM, Ma DL, CheungYW, et, al. Proteomics, Vol. 8(2008), pp.3105-3117.

Google Scholar

[3] Ma DD, Lu HX, Xu LS, et, al. JInt Med Res, Vol. 37(2009), pp.631-640. (In Chinese).

Google Scholar

[4] Xingyu Pan, Mingce Zang, Hongwei Li. Chinese Journal of Immunology, Vol. 16(2000), p.460. (In Chinese).

Google Scholar

[5] Chenyuan Li, Yanhua Liu, Shuhua Li, et, al. Journal of Jinzhou Medical College, Vol. 24(2003)p.40. (In Chinese).

Google Scholar

[6] Hong F, Xiao W, Ragupathi G, et, al. Planta Med, Vol. 3(2007), p.41.

Google Scholar

[7] Tin MM, Cho CH, Chan K, et, al. Carcinogenesis, Vol. 28(2007), pp.1347-1355.

Google Scholar

[8] Jang TJ, Kang HJ, Kin JR, et, al. Carcinogenesis, Vol. 25(2004), pp.1853-1858.

Google Scholar

[9] Teng Xu, Cunkuan Xue, Xuebin He. West Pharmaceutical Journal, Vol. 20(2005)487-489. (In Chinese).

Google Scholar

[10] Teng Xu, Cunkuan Xue, Xuebin He. China Pharmacist, Vol. 9(2006), pp.397-399. (In Chinese).

Google Scholar

[11] Shulan Yuan, Jiexiu Wang, Cancer, Vol. 22(2003), p.1363. (In Chinese).

Google Scholar

[12] Yuan Jiang, Li Xiong. Chinese and Western Medicine on Liver Diseases, Vol. 15(2006), pp.27-29. (In Chinese).

Google Scholar

[13] Tu S H, Hu Y H, Zeng K Q, et, al. Anhui Tradit Chin Med Coll, Vol. 25(2006), pp.27-29.

Google Scholar

[14] Efferth T, Volm M. In Vivo, Vol. 19(2005), pp.225-232.

Google Scholar